🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Last week, CLINUVEL announced that the Company has met its recruitment target in its phase III trial (CUV105) of SCENESSE® (afamelanotide 16mg) in vitiligo. Learn more about CUV105 here: clinuvel.com/2025/05/clinuv… $CUV.AX #Biotech #Biopharma #Vitiligo #ASX #Pharmaceuticals

According to the American Porphyria Foundation (American Porphyria Foundation), the true prevalence of the family of #porphyrias remains unknown, but clinicians suggest that a range of 1 per 500–50,000 of population is probable. Erythropoietic protoporphyria (#EPP) is estimated to impact

Advocating for people with porphyria is key to increasing awareness of this family of disorders and advancing care for patients. Desiree Lyon knows first-hand what it is like to live with porphyria. This diagnostic odyssey inspired her to co-found the American Porphyria

Supporting good mental health for all is one of the key goals of #MentalHealthAwarenessWeek. Visible skin conditions like #vitiligo carry additional psychosocial burdens, which affect the wellbeing of those who live with the condition. At #AAD2025, Reuben Sam, model and

This #PorphyriaAwarenessWeek, we’re calling for healthcare professionals to learn more about EPP in order to speed up the diagnostic process for patients. Learn more here: clinuvel.com/pharmaceutical… #Porphyria #RareDiseases #EPP #ThinkPorphyria #Diagnosis

We conclude Porphyria Awareness Week today with #GlobalPorphyriaDay. This annual initiative brings together the international porphyria community to raise awareness of this group of rare disorders, with people being encouraged to wear purple to mark the occasion. CLINUVEL is

Living with erythropoietic protoporphyria (EPP) can be physically challenging due to phototoxic reactions. However, the psychosocial of living with this rare condition is often misunderstood. A 2022 student research paper by McKillop and Pedersen examined the effects of living

#ICYMI Read more about this announcement on clinuvel.com. #vitiligo #clinicaltrial #melanocortins #repigmentation #treatment

The CLINUVEL team had the pleasure of attending last week’s Société Française de Photodermatologie (SFPD) Congress in Paris, France. The congress explores pigmentary disorders, their prevalence, their consequences, and recently proposed therapeutic avenues. Notable highlights

The CLINUVEL team are proud to attend the European Academy of Dermatology and Venereology (@EADV) Symposium taking place in Prague, Czech Republic on 22–24 May. This international gathering is devoted to dermatology and venereology, offering a dynamic platform for exchanging

Yesterday, CLINUVEL’s Head of Investor Relations, Malcolm Bull presented to Australian investors at the Wilsons Advisory Rapid Insights Conference in Sydney. The presentation included a summary of CLINUVEL’s current clinical programs, strong financial positioning and commercial

At least once a year, CLINUVEL’s Board and executive team spends intensive time together focusing on key issues and objectives for the business. This week, the team has travelled to #Singapore to visit the #VALLAURIX R,D&I Centre and receive updates on the latest developments

Treatment approaches for vitiligo have varied throughout history, from natural remedies to dietary changes. In ancient India, treatment attempts included herbal pastes and sunlight exposure, while the others created creams from Psoralea corylifolia. More recently, therapies

From herbal remedies to narrowband UVB therapy and topical JAK-inhibitors, vitiligo treatment has come a long way. There is still much work to be done in order to create a safe, effective therapy that offers the potential for repigmentation and can be used long-term. CLINUVEL

The CLINUVEL team looks forward to attending the Jefferies Global Healthcare Conference in New York City this week. The event will welcome over 3,000 leading executives, institutional investors, private equity investors & VCs to address near- and long-term investment

CLINUVEL has released an extended global update on the vitiligo landscape and the Company’s vitiligo program. Read the full release here: clinuvel.com/wp-content/upl… $CUV.AX #Biotech #Biopharma #Vitiligo #ASX #Pharmaceuticals #ClinicalResearch #ClinicalTrials

Patient advocacy is vital to ensure earlier diagnoses, access to proper care, and funding for research. For patients living with #Porphyria, advocating for themselves can be extremely challenging due to the debilitating nature of this family of disorders. CLINUVEL proudly

The San Francisco Dermatological Society Annual Conference is taking place between 6-8 June. CLINUVEL is proud to be a sponsor of the event which brings together some of the most prominent minds in dermatology to share knowledge and their expertise in the field. On Day 2 of the

The latest CLINUVEL update on vitiligo highlights the estimated total addressable market for vitiligo treatment and the key factors to personalising treatment for patients. Learn more in the update here: clinuvel.com/wp-content/upl… $CUV.AX #Biotech #Biopharma #Vitiligo #ASX

Last week, our team attended the Jefferies Global Healthcare Conference in New York City. The conference brought together over 3,000 leading executives and investors to discuss the biopharma landscape at a time when our industry is navigating complex challenges. A standout